Jézéquel A M, Mancini R, Rinaldesi M L, Macarri G, Venturini C, Orlandi F
Institute of Experimental Pathology, University of Ancona School of Medicine, Italy.
J Hepatol. 1987 Oct;5(2):174-81. doi: 10.1016/s0168-8278(87)80570-6.
Hepatic fibrosis has been induced in rats by low doses of dimethylnitrosamine (DMN) and special attention has been paid to early morphological events. DMN (10 microliter/kg body wt., i.p.) was given 3 days a week for 3 weeks to Sprague-Dawley rats. Liver samples were taken on days 7, 14, 21, 28 and 35 and examined by light and electron microscopy. Hemorrhagic necrosis, mainly centrolobular, was evident on day 7, with disruption of the sinusoidal lining, and widening or disappearance of the spaces of Disse invaded by erythrocytes and lymphocytes. Large granular lymphocytes similar to pit cells were also present in close contact with hepatocytes. At day 14, fibrotic septa were associated with cells bearing 'transitional' features between those of lipocytes, myofibroblasts and fibroblasts. Hepatocytes showed foci of increased smooth endoplasmic reticulum, and altered sinusoidal and canalicular membranes. At day 21, all animals showed nodularity of the parenchyma, with evidence of micronodular cirrhosis associated with ascites in two animals. At day 35 (19 days after cessation of treatment) there was little residual inflammation, but well-defined micronodules were still present in all animals. This shows that, in the rat, 3-week treatment with a low dose of DMN produces micronodular cirrhosis following diffuse hemorrhagic necrosis without steatosis. The response of the animals was uniform and reproducible. Lesions of the sinusoidal wall and of membranes of liver cells associated with the inflammatory reaction appeared prominent.
低剂量二甲基亚硝胺(DMN)可诱导大鼠发生肝纤维化,且已特别关注早期形态学变化。每周3天,连续3周给Sprague-Dawley大鼠腹腔注射DMN(10微升/千克体重)。在第7、14、21、28和35天采集肝脏样本,进行光镜和电镜检查。第7天可见主要为小叶中央的出血性坏死,伴有窦状隙内衬破坏,狄氏间隙增宽或消失,有红细胞和淋巴细胞侵入。还可见与肝细胞紧密接触的类似于贮脂细胞的大颗粒淋巴细胞。第14天,纤维化间隔与具有介于脂肪细胞、肌成纤维细胞和成纤维细胞之间“过渡”特征的细胞相关。肝细胞显示滑面内质网增加的灶状区域,以及窦状隙和胆小管膜改变。第21天,所有动物均出现实质结节,两只动物有与腹水相关的小结节性肝硬化证据。第35天(停止治疗后19天),残留炎症很少,但所有动物仍有明确的小结节。这表明,在大鼠中,低剂量DMN 3周治疗后,在无脂肪变性的弥漫性出血性坏死后会产生小结节性肝硬化。动物的反应一致且可重复。与炎症反应相关的窦状壁和肝细胞细胞膜病变较为突出。